Actively Recruiting

Age: 18Years - 90Years
All Genders
Healthy Volunteers
NCT05442463

Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

Led by University of Calgary · Updated on 2025-03-27

200

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

1. to investigate the association between route of administration of exogenous estrogen (transdermal vs. oral) and cardiorenal risk in cisgender (gender identity aligning with sex at birth) and transgender (gender identity not aligning with sex at birth) women. 2. to investigate the association between exogenous testosterone exposure and cardiorenal risk in cisgender (gender identity aligning with sex at birth) and transgender (gender identity not aligning with sex at birth) men.

CONDITIONS

Official Title

Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

Who Can Participate

Age: 18Years - 90Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 90 years
  • Taking hormones orally or non-orally (either estrogen, progesterone or testosterone)
Not Eligible

You will not qualify if you...

  • Cardiovascular disease including symptoms or history of myocardial ischemia, arrhythmias, valve abnormalities, or abnormal ECG at screening
  • Cerebrovascular disease such as transient ischemic attacks or stroke
  • History of hypertension (blood pressure greater than 140/90 or use of blood pressure medications)
  • Estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m2
  • Diabetes mellitus defined by history, use of diabetes medications, or fasting glucose over 7 mmol/L
  • Current smoker
  • Previous history of preeclampsia
  • Use of anabolic steroids, corticosteroids, or non-steroidal anti-inflammatory drugs, or as determined by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Calgary

Calgary, Alberta, Canada, T2N 4Z6

Actively Recruiting

Loading map...

Research Team

D

Darlene Y Sola, BScN

CONTACT

V

Victoria Riehl-Tonn, BN

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here